Elanco

Elanco Animal Health Incorporated

Company type	Public
Traded as	NYSE: ELAN Russell 1000 component
Industry	Pharmaceutical (animal)
Founded	1954
Headquarters	Greenfield, Indiana, U.S.
Key people	R. David Hoover (Chairman) Jeff Simmons (CEO)
Products	Pharmaceutical drugs (animal)
Revenue	US$4.765 billion (2021)[1]
Operating income	–US$0.567 billion (2021)[1]
Net income	–US$0.472 billion (2021)[1]
Total assets	US$16.483 billion (2021)[1]
Total equity	US$7.538 billion (2021)[1]
Number of employees	10,200 (2021)[2]
Website	elanco.com

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.^[3]